NEAT1 and cancer: Additionally, information is provided on whether NEAT1 and its downstream targets have been validated in experiments as cancer biomarkers associated with cancer cell growth, metastasis, disease recurrence, survival, drug resistance, and immune escape (Supplementary Fig. S10).